(The FASEB Journal. 2000;14:231-241.)
© 2000 FASEB
The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains
BRIAN K. KAY*1,
MICHAEL P. WILLIAMSON
and
MARIUS SUDOL
* Department of Pharmacology, University of Wisconsin-Madison, Madison, Wisconsin 53706-1532, USA;
Department of Molecular Biology and Biotechnology, University of Sheffield, Western Bank, Sheffield S10 2TN, United Kingdom;
Department of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, New York, New York 10029-6574, USA
1Correspondence: Department of Pharmacology, University of Wisconsin, 1300 University Ave., Madison, WI 53706-1532, USA. E-mail: bkkay{at}facstaff.wisc.edu
 |
ABSTRACT
|
|---|
Acommon focus among molecular and cellular biologists is the
identification of proteins that interact with each other. Yeast
two-hybrid, cDNA expression library screening, and
coimmunoprecipitation experiments are powerful methods for identifying
novel proteins that bind to ones favorite protein for the purpose of
learning more regarding its cellular function. These same techniques,
coupled with truncation and mutagenesis experiments, have been used to
define the region of interaction between pairs of proteins. One
conclusion from this work is that many interactions occur over short
regions, often less than 10 amino acids in length within one protein.
For example, mapping studies and 3-dimensional analyses of
antigenantibody interactions have revealed that epitopes are
typically 47 residues long (1)
. Other examples include
protein-interaction modules, such as Src homology (SH) 2 and 3
domains, phosphotyrosine binding domains (PTB), postsynaptic
density/disc-large/ZO1 (PDZ) domains, WW domains, Eps15 homology (EH)
domains, and 143-3 proteins that typically recognize linear regions
of 39 amino acids. Each of these domains has been the subject of
recent reviews published elsewhere (2
3
4
5
6
7)
. Among the
primary structures of many ligands for proteinprotein interactions,
the amino acid proline is critical. In particular, SH3, WW, and several
new protein-interaction domains prefer ligand sequences that are
proline-rich. In addition, even though ligands for EH domains and
143-3 domains are not proline-rich, they do include a single proline
residue. This review highlights the analysis of those proteinprotein
interactions that involve proline residues, the biochemistry of
proline, and current drug discovery efforts based on proline
peptidomimetics.Kay, B. K., Williamson, M. P., Sudol, M. The
importance of being proline: the interaction of proline-rich motifs in
signaling proteins with their cognate domains.
 |
SH3 DOMAINS
|
|---|
SH3 DOMAINS ARE 5070 amino acids long and often
present in eukaryotic signal transduction and cytoskeletal proteins
such as Abl, actin-binding protein, Bem1, cdc25, cortactin, calcium
channel ß1B2 subunit, Grb2, myosin, Nck, PI3K regulatory subunit,
PLC
, ras GTPase activator, spectrin, and tight junction protein
ZO-1. Computer-aided analysis of protein sequences has even suggested
that SH3 domains may also exist in bacteria (7a)
. For a
long time, the function of the SH3 domain in eukaryotes was enigmatic;
however, since the domain was present in so many cytoskeletal proteins,
it was assumed to play a role in mediating proteinprotein
interactions (8)
or directing cell compartmentalization
(9)
. The SH3 domain clearly had an important function for
some proteins, as mutations in the SH3 domains of cellular Src
(10)
and Abl (11
, 12)
are activating.
The ligand specificity of SH3 domains was first revealed when a
-cDNA expression library was screened with a glutathione
S-transferase (GST)-Abl SH3 fusion protein (13)
. Two
different cDNA clones were isolated and the regions responsible for
their binding to the Abl SH3 domain were shown to be proline-rich
segments (14)
. Examination of other SH3 ligands identified
in the same manner (15
16
17)
has suggested that SH3 domains
recognize proline-rich sequences containing the core PxxP, where x
denotes any amino acid (18
, 19)
.
With the advent of combinatorial peptide libraries, ligand specificity
has been determined rapidly for a large number of different SH3
domains. The SH3 domains of Src and the phosphatidyl inositol 3-kinase
(PI3K) regulatory subunit select proline-rich sequences from peptides
displayed on beads (20)
and phage (21
22
23)
.
Phage libraries have also been used to identify the specificity of SH3
domains from Abl, amphiphysin I, cortactin, Crk, Fyn, Grb2, Lyn, Nck,
p53BP2, PI3K, PLC
, Tsk, and Yes (22
, 24
25
26
27)
. The
optimal ligand preference for each domain varies around the PxxP core
(Table 1
), demonstrating that a great deal of proteinprotein interaction
specificity can be encoded by proline-rich sequences.
Investigations into the structure of peptide-SH3 complexes have shown
that peptide ligands can bind in two orientations with respect to the
SH3 domain (28
, 29)
. The peptides, which bind in either an
N to C or C to N terminal orientation relative to the SH3 domain, have
been classified as either class I or class II ligands, respectively.
The orientation of the peptide is dictated by the location of a
positively charged residue, relative to the PxxP core, which forms a
salt bridge with an acidic residue in the SH3 domain (Fig. 1A
). Thus, peptides with the motif +xxPxxP and PxxPx+ (where +
refers to a positively charged amino acid) correspond to class I and
class II motifs, respectively. Some SH3 domains, like that present in
Src, have the capacity to bind peptides of either class (i.e.,
RPLPPLP and PPVPPR; where
the scaffolding prolines are underlined), although the biological
implications of this are unclear. (One frequently raised possibility is
that ligand binding in two orientations could access different partners
in multicomponent protein complexes.) In both orientations, not only do
proline and leucine side-chains fit into the same hydrophobic pockets
on the SH3 domain (Fig. 1A
), but also very similar hydrogen
bonds can be made from peptide carbonyls in the proline-rich ligand
(30)
. Typically, the Kd values of
synthetic peptides binding SH3 domains are 1100 µM, although amino
acid analoging experiments have led to the development of higher
affinity peptide ligands (31)
. The
Kdvalues of full-length proteins that interact with
SH3 domains are significantly lower than for peptides; for example, the
HIV Nef protein binds to the Hck SH3 domain with a
Kd of ~250 nM
(32)
.

View larger version (58K):
[in this window]
[in a new window]
|
Figure 1. A) Three-dimensional model of how class I and II ligands
bind to SH3 domains, based on the structure of the Src SH3 domain
(28)
. The proteins topological surface is shown in gray,
with acidic residues colored in blue. The ligands are RALPPLPRY, a
class I ligand (below) and AFAPPLPRR, a class II ligand (above). All
residues in the ligands are colored gray, except for the recognition
prolines (yellow), flanking prolines (cyan), leucine (brown), and
arginine (red). The side-chain of the first arginine in the class II
ligand has been omitted for clarity. The peptides interact with the two
LP dipeptide pockets (left and center) and the acidic specificity
pocket (right), which form grooves in the surface separated by ridges.
The NH2- and carboxyl-termini of the peptides are denoted
with N and C, respectively. B) Three-dimensional model
of how peptide ligands bind to the YAP65 WW domain. The proteins
topological surface is shown in white, with three of the key residues
shown in green (from left to right, Trp39, Tyr28, and Leu30). The
peptide ligand is shown in gray, except for the core prolines (yellow),
which sit in a shallow pocket formed by Trp39 and Tyr28, the flanking
prolines (cyan), and the tyrosine (red), which sits over the
hydrophobic pocket containing Leu30. C) A space-filling
model of a polyproline helix, colored as green, carbon; red, oxygen;
blue, nitrogen; white, hydrogen.
|
|
There are three shallow pockets within the SH3 domain where the
peptide ligands bind. Two of the pockets are 25 Å long and 10 Å wide,
large enough to accommodate each of the prolines in the PxxP motif,
accompanied by a hydrophobic residue (i.e., A, I, L, V, and P). These
two pockets are parallel to each other and have been termed the LP
dipeptide pockets (33)
. A third pocket, termed the
specificity pocket is bound by two loops (i.e., RT, nSrc) of the
SH3 domain (34)
. Within this pocket sit residues either
NH2- or carboxyl-terminal of the positively
charged residue in class I or class II ligands, respectively.
Besides the two orientations described above, a third SH3 ligand
corresponding arrangement has been described. In this arrangement,
residues spaced apart in a protein sequence come together, because of
the tertiary structure of the protein, to interact with the
peptide-binding groove of the SH3 domain. One example of this
arrangement occurs within the p53 binding protein, p53BP2. The SH3
domain of p53BP2 interacts with two segments of the L3 loop of p53, in
a manner analogous to the contacts made in canonical SH3-PxxP
complexes, with the positions and orientations of the interacting
residues determined by the overall 3-dimensional structure of p53,
rather than as part of a PxxP core (35)
. It should be
mentioned that p53 does contain two PxxP motifs that have been shown to
be involved in growth suppression through interactions with other SH3
domain-containing cellular proteins (36)
.
Recently, a novel ligand sequence has been observed for the SH3 domain
of the epidermal growth factor receptor substrate, Eps8, which has been
discovered to form intertwined dimers (37)
. Because the
site of dimerization includes the interface of the SH3 domain that
typically interacts with PxxP motifs, the specificity of the
intertwined dimers is altered. Analysis of the ligand preferences of
this dimer has revealed it to recognize not PxxP, but PxxDY instead
(37a)
. It will be interesting to learn how common this
unusual arrangement is among other SH3 domains.
Analysis of several SH3 domain interactions has suggested that
some form stable complexes and others may be regulated in the cell. For
example, the interaction between Sos and Grb2, which is constitutively
complexed in cells, can be inhibited by phosphorylation of
serine/threonine residues in the proline-rich carboxyl-terminal segment
of Sos, after receptor activation (38)
. Phosphorylation of
a PxxP site in the Wiskott-Aldrich syndrome protein (WASP) can inhibit
its interaction with the SH3 domain of the cytoskeletal-associated
protein, PSTPIP (39)
. Although the sites have not been
mapped, phosphorylation of the Drosophila-enabled (Ena)
protein by Abl can inhibit the interaction of Ena with certain SH3
domains (40)
. Finally, binding of phosphopeptide ligands
to the Crk SH2 domain alters its conformation such that a proline-rich
insert in the Crk SH2 domain becomes an SH3 domain-binding site
(41)
. Very likely, the interaction between other SH3
domains and ligand-containing proteins is regulated by allosteric
changes (42)
. A recent publication capitalizes on this
conclusion by generating temperature-sensitive SH3 domains for the
purpose of dissecting SH3 domain function in vivo
(43)
. Such an approach may be applicable to other protein
interaction modules.
Although most SH3 domain-mediated interactions are
intermolecular, several intramolecular interactions have been
described. In Src (44
, 45)
, Hck (46
, 47)
, and
Abl (48)
, the SH3 domains interact with a linker region
between the SH2 and catalytic kinase domains of these proteins, thereby
adopting a catalytically inactive conformation (49)
. In
some cases, this conformation is stabilized by the interaction of the
SH2 domain with phosphorylated tyrosine residues present near the
carboxyl termini of such proteins. The elucidation of these various
intramolecular interactions explains the observations that mutations in
the SH3 domains of Src (10)
and Abl (50)
are
activating, because the mutant forms fail to adopt an inactive
conformation. Another example occurs in the cellular oncogene, Itk,
where a proline-rich sequence, KPLPPTP (residues 155160) binds to an
SH3 domain (residues 170232) within the same protein
(51)
. The intramolecular interaction is quite stable, even
without the involvement of an SH2 domain, although the interaction of
the Itk SH3 domain with a soluble form of the KPLPPTP peptide sequence
is undetectable.
 |
WW DOMAINS
|
|---|
WW domains are small globular modules composed of 3840 amino
acids. The name refers to two conserved tryptophan (W) residues that
are spaced 2022 amino acids apart and play an important role in the
structure and function of the domain (52)
. The WW domain
was initially identified by computer-aided analysis of imperfectly
repeated sequences in the murine form of Yes-associated protein (YAP;
http://www.bork.embl-heidelberg.de/Modules.ww-gif.html).
Although the WW domain resembles the SH3 domain functionally by
displaying affinity toward proline-rich ligands, their structures are
distinct (53
54
55)
. WW domains have an antiparallel
three-stranded ß-sheet structure that forms a shallow binding pocket
for ligands containing PPxY or PPLP core motifs, usually flanked
by additional prolines (53
, 56
, 57)
. Recently another
motif, with a preliminary consensus PxxGMxPP (Table 1)
, was proposed
for ligands interacting with a subset of WW domains present in proteins
participating in the pre-mRNA splicing machinery (58)
.
These WW domains have a distinguishing feature of three consecutive
tyrosine residues located centrally within them.
The first structure of a WW domain was that of human YAP in
complex with its cognate ligand, solved by Nuclear Magnetic Resonance
spectroscopy (54)
. Shortly thereafter, the structure of
Pin1 WW domain was solved by X-ray (59)
. These two
structures are almost completely superimposable. The WW domain is the
most compact globular structure known to occur naturally, and it is the
smallest ß-sheet module that folds as a monomer in solution without
disulfide bridges or cofactors (60)
. The hallmarks of the
binding pocket of the WW domain of human YAP include three hydrophobic
amino acids, leucine, tyrosine, the second conserved tryptophan and
histidine, as confirmed by structural and mutational studies
(54)
. Two prolines of the ligand (PPxY) form
van der Waals contacts with the second tryptophan, whereas the terminal
tyrosine of the ligand fits into a hydrophobic pocket and is
coordinated by a hydrogen bond from the conserved histidine residue
(Fig. 1B
). The Kd of interaction for
WW-ligand complex formation is in the high nM to
low µM values for proline-rich ligands, and in the low µM values
for phosphoserine or phosphothreonine containing ligands, depending
upon the domain-ligand pair, buffer conditions, and the binding assay
(57
, 61
, 62)
. Phosphorylation of the terminal tyrosine in
the ligand (PPxY) abolishes the binding in vitro,
suggesting that this modification could represent a negative
regulation mechanism for a subset of WW domains in
vivo (63)
.
Immediately after its discovery, the WW domain attracted attention
because the signaling complexes it mediates have been implicated
directly or indirectly in several human diseases including Liddles
syndrome of hypertension, muscular dystrophy, and Alzheimers and
Huntingtons diseases (64
65
66
67
68
69)
. Liddles syndrome
results from genetic lesions that affect ß and
subunits of the
amiloride-sensitive epithelial sodium channel (70)
. Most
of the mutations that have been reported in patients with Liddles
syndrome represent deletions that encompass a minimum of 12 residues,
which includes the PPxY motif. Three independent Liddles syndrome
patients were recently characterized who have single-point mutations in
one of the three crucial positions of the PPxY motif in the ß subunit
of the sodium channel (70
71
72)
. These mutations (i.e.,
P615S, P616L, and Y618H) substantiate biologically the conclusions
first generated by in vitro alanine scanning of a short
region within YAP WW domain interacting proteins (53
, 63)
.
Liddles mutations abolish binding of sodium channel subunits to the
Nedd-4 protein, which in addition to containing three WW domains
includes an ubiquitin-ligase catalytic domain (66
, 73
, 74)
. Nedd-4 normally participates in targeting the epithelial
sodium channel subunits for ubiquitin-directed proteolysis, but in
mutant epithelial cells the channel has a long half-life, leading to a
sodium imbalance and subsequently high blood pressure. Given that
epithelial sodium channels are phosphorylated on serine, threonine, and
possibly tyrosine residues, it will be interesting in the future to
learn whether or not these modifications modulate the interaction
between the sodium channel and the WW domains of Nedd-4 and thereby
change the rate of channel degradation (75
, 76)
.
Recently, the PPxY motif has been observed in a number of transcription
factors (i.e., c-Jun, AP2, NF-E2, C/EBP
, PEBP2/CBF) where
it may play a role in transcriptional activation. For example, the
hematopoietic transcription factor, NF-E2, contains two PPxY motifs
that can be recognized by the WW domains contained within certain
ubiquitin ligases (61
, 77)
. Interaction of WW
domain-containing proteins with this motif is likely to be important
for transcriptional activation, as deletion of one of the two PPxY
motifs in NF- E2 (61)
or the single copy in PEBP2
(78)
inhibits their ability to transactivate genes. Thus,
the presence of the PPxY motif within transcription factors may
function to recruit WW domain-containing proteins such as YAP
(78)
and Npw38 (79)
, which have been
discovered to act as transcriptional coactivators. Conversely, it is
possible in some cases that WW domain-containing proteins serve to
negatively regulate transcription. Recently, PQBP-1, a novel
polyglutamine tract binding protein with a WW domain, has been shown to
inhibit transcription activation by Brn-2, although the role of its WW
domain is yet to be defined (80)
.
 |
OTHER MODULES/PROTEINS THAT BIND PROLINE-RICH LIGANDS
|
|---|
The number of modules that bind proline-rich ligands is increasing
(81)
. The EVH1 (Enabled, VASP,
Homology 1) domain is a protein interaction
module present in Ena, vasodilator-stimulated phosphoprotein (VASP),
and the WASP family of proteins that regulate the dynamics of the actin
cytoskeleton (82
83
84
85)
. EVH1 domains bind the proline-rich
consensus sequence (D/E)FPPPP, which is present in ActA, a protein on
the surface of the bacterial pathogen Listeria monocytogenes
as well as in vinculin and zyxin, two protein components of focal
adhesions (84)
. The EVH1 domain has also been detected in
Homer, a neuronal protein enriched in excitatory synapses
(86)
, and which binds to proline-rich motifs (i.e., PPxxF)
within glutamate and inositol trisphosphate receptors
(86
87
88)
and Shank, a postsynaptic density protein
(89)
. Recently, the 3-dimensional structure of the EVH1
domain has been solved for the mouse Ena protein (90)
.
Much like SH3 and WW domains, aromatic residues within the EVH1 domain
create an interaction surface for proline-rich peptide ligands that
adopt a polyproline II (PP II) conformation (see below), even though
the binding site is V-shaped instead of flat.
Two other proteins that bind proline-rich peptides should be mentioned
as well. A cytosilic protein, CD2 binding protein (CD2BP2), was
recently described in a pathway that regulates CD2-triggered T
lymphocyte (91)
. The CD2BP2 protein contains a domain that
was shown to interact with a tandemly repeated PPPGHR sequence (Table 1)
and its structure was recently solved (91a)
. Profilin
was originally described as a regulator of actin polymerization
(92)
. Within its structure, profilin, like SH3, WW, and
EVH1 domains, exposes stacked aromatic and hydrophobic residues to form
an interface that binds proline-rich ligands (82
, 93
, 94)
.
The binding of polyproline has been shown to be essential for profilin
function (95)
; profilin require a minimum of 68
consecutive prolines for high affinity (92
, 94
, 96)
. Some
of these cores are flanked by leucines, providing a basis for
speculation about degeneracy of certain proline-rich ligands that might
interact with both profilin and SH3 and WW domains with similar
affinities (81
, 94
, 97)
. Indeed, it has been speculated
that profilin may provide the link between signaling pathways and
remodeling of the actin cytoskeleton (98)
, a good example
of the versatile biological role made possible by the promiscuity
exhibited by proline-rich regions and their ligands.
 |
BIOPHYSICAL REASONS WHY PROLINE IS A COMMON BINDING MOTIF
|
|---|
Proline is unique among the 20 common amino acids in having the
side-chain cyclized onto the backbone nitrogen atom. This means that
the conformation of proline itself is limited, with backbone
angles
of ~-65°. It also restricts the conformation of the residue
preceding the proline because of the bulk of the
N-substituent and results in a strong preference for a
ß-sheet conformation (99)
. As a consequence, polyproline
sequences tend to adopt the PP II helix, which is an extended structure
with three residues per turn. This implies that the two prolines in the
SH3 domain ligand core, PxxP, are on the same face of the helix and are
thus well placed to interact with the protein. The PP II helix is an
unusual structure: the prolines form a continuous hydrophobic strip
round the surface of the helix, while the backbone carbonyls present
ideal hydrogen bonding sites, being both conformationally restricted
(and therefore poorly hydrated) and electron-rich (Fig. 1C
).
Therefore, PP II helices present an easily accessible hydrophobic
surface, as well as a good hydrogen-bonding site. The accessibility of
PP II helices is greatly enhanced by the fact that they are frequently
found either at the NH2- or carboxyl termini of
proteins where they form extended structures that have been described
as sticky arms (100)
.
PP II helices are common in globular proteins with solved 3-dimensional
structures (101)
, where they are generally solvent exposed
and amphipathic (102)
. They are probably even more common
in proteins that have not been characterized structurally, because they
tend to occur in extended regions that are hard to characterize using
X-ray diffraction or NMR spectroscopy. It does not require an unbroken
sequence of prolines to make a PP II helix; in fact, this type of
left-handed helix can form in globular proteins without protein in the
helix (101)
. By contrast, a single nonproline residue may
be enough to interrupt a PP II helix in a completely exposed chain
(103)
, and it has commonly been observed that the flanking
prolines around or within the core PxxP SH3 ligand sequence function to
maintain the required PP II structure (104)
.
The relative rigidity of polyproline stretches means that they lose
little conformational entropy on binding and thus bind more favorably
than other exposed (i.e., nonglobular) peptide sequences. Of course,
proline-rich sequences cannot bind as tightly as globular domains can;
however, weaker binding can be of great advantage, as it allows the
binding of proline-rich regions to be modulated rapidly. It also
permits large changes to be made in Kd by small
changes in the sequence of the proline-rich sequence or of its binding
domain, either by sequence changes or by covalent modification such as
phosphorylation. The entropic stabilization has been estimated to be
~1 kcal mol-1 per amino acid, both
experimentally (105)
and theoretically (100)
.
The interaction is largely hydrophobic and, therefore, does not require
highly complementary surfaces. This accounts for the large sequence
variability seen in polyproline binding and for the remarkable ability,
described above, of SH3 domains to bind polyproline sequences in both
orientations, two features that give proline-rich ligands great
versatility in signaling pathways (30)
.
Because proline-rich regions are exposed, their on-rates and off-rates
for binding can be very fast. However, the price to be paid for these
fast rates is that the complexes are not structurally very well defined
on a nanometer scale. Therefore, proline-rich sequences are commonly
found in situations requiring the rapid recruitment or interchange of
several proteins, such as during initiation of transcription, signaling
cascades, and cytoskeletal rearrangements. Here, the role of
proline-rich regions is not to provide a structurally defined complex
but rather to bring proteins together in such a way that subsequent
interactions are more probable. For example, the proline-rich region on
Sos1 binds to the two SH3 domains of Grb2, thereby bringing Sos1 to the
cell membrane following receptor activation, where Sos1 in turn then
activates the Ras pathway (100)
. It is significant that
the proline-rich protein is part of an adaptor system bringing
together other proteins. Proline-rich regions also seem to participate
in other such adaptor systems, for example, in synaptic vesicle
endocytosis (106)
.
Some proteins contain tandem proline-rich repeats. These generally seem
to have a different function, in that they are involved in the
formation of networks of interactions that lead to precipitation or
rigid meshes, as, for example, in salivary protein/polyphenol
interactions or insect eggshells (100). An interesting role of multiple
repeats appears to be in the actin-based movement of Listeria
monocytogenes, where each repeat, within the EVH1 domain of ActA,
contributes to the rate of actin-based movement (107). This latter
provides yet another example of the adaptor role of proline-rich
regions. The binding of ActA (as well as zyxin and vinculin) to VASP
and of VASP to profilin are both mediated by proline-rich regions, thus
using proline-rich ligands indirectly to bring together ActA and actin
(82).
 |
THE REGULATION OF PROLINE-DEPENDENT INTERACTIONS
|
|---|
We still have much to learn about the regulation of the
interactions mediated by proline-rich regions. It is clear that an
important mechanism is provided by intramolecular ligands, as described
above for SH3 domains (42)
. Because an intramolecular
interaction is generally more energetically favorable than the
equivalent intermolecular interaction, the manipulation of
intramolecular interactions, by conformational change or
phosphorylation, is likely to be common.
Phosphorylation is a very common mechanism for regulation of protein
function and is used extensively in the context of proline-rich regions
(108)
. Proline-rich regions often contain serine or
threonine, which frequently occur as the residue immediately preceding
the proline. Specific enzymes control phosphorylation and
dephosphorylation: for example, the microtubule-associated protein 2
(MAP2) is developmentally regulated by phosphorylation, which controls
its binding to tubulin via a proline-rich region
(109)
. Both MAP2 kinase and p34cdc2
(108)
have a preference for the sequence Px(S/T)P, in
which the two prolines are separated by two residues, suggesting that
the proline-dependent kinase may well be recognizing a PP II
conformation in the substrate. As noted above, some WW domain ligands
represent target sites for proline-directed serine-threonine kinases
and have a phosphorylatable residue frequently in the vicinity of the
prolines. When decorated by phosphorylation, the serines and threonines
that flank selected PPxY cores of WW domain ligands have the ability to
positively or negatively regulate the binding (Korosi, T., Chang, A.,
and Sudol, M., unpublished results). Very recently, WW domains of two
proteins, Ess1/Pin1 and Nedd-4, were shown to recognize phosphoserine
or phosphothreonine containing ligands (Table 1)
in a
phosphorylation-dependent manner (62)
. It is likely that,
in addition to the PPxY binding pocket, these WW domains may have
another crevice that accommodates the phosphoserine or phosphothreonine
residues. It remains to be determined how phosphorylation affects the
ligand binding of the 160 WW domains known so far.
It has also been shown that phosphorylation changes the
cis/trans interconversion rate of the peptide bonds between
serine/threonine and proline. A candidate enzyme is the peptidyl-prolyl
cis/trans isomerase, Ess1/Pin1, which catalyzes the
isomerization of phosphorylated Ser/Thr-Pro (110)
. This
activity is essential for progression through the cell cycle
(111
, 112)
and restoration of the microtubule-binding
activity of
, a protein component of neurofibrillar tangles of
Alzheimers patients (113)
. Peptide bond isomerization
could alter binding either directly, by changing the shape of the
ligand, or indirectly, by affecting enzyme-catalyzed hydrolysis of the
bond. Therefore, it will be of great interest when the 3-dimensional
structures of the Ess1/Pin1 WW domain complexed with its phosphorylated
ligands (59
, 62)
are determined.
Proline can have several other specific functions in proteins
unrelated to the theme of binding elaborated here. Proline can induce
ß-turns, particularly if preceded by tyrosine (114)
or
followed by phenylalanine or tryptophan residues (115)
.
Proline can also introduce bends in transmembrane helices, and because
of its rigidity can act as a conformational switch, allowing parts
of proteins to adopt alternative conformations such as domain-swapped
dimers (116)
.
 |
POLYPROLINE PEPTIDOMIMETICS
|
|---|
With the elucidation of peptide sequences that bind to specific
domains, it should be possible to use peptide ligands to interfere with
specific SH3 domains in the cells. Ligands for the SH3 domains of Src
and Lyn have been injected into oocytes (23)
or
electroporated into mast cells (117)
and led to a
biological response (i.e., acceleration of progesterone stimulated
oocyte maturation, inhibition of mast cell activation). Although most
peptides fail to cross the membrane on their own, in the future it
should be possible to link them to peptide segments of
Antennapedia (118
119
120)
, Kaposi fibroblast
growth factor (121)
, or HIV Tat (122)
, which
do have the capacity to cross the plasma membrane. Recently, such an
approach has been used to introduce a dimeric peptide segment of Sos
into fibroblasts where it was observed to block the endogenous Ras
signaling pathway (123)
. Work from the laboratory of
Stephan Feller (University of Wurtzburg) has shown that a high-affinity
peptide ligand for the NH2-terminal SH3 domain of
Crk, when attached to a cell permeable peptide sequence, has biological
activity when added to tissue culture cells (Kardinal, C., and Feller,
S., unpublished observation).
A number of proline-rich peptides, which are antimicrobial and adopt a
PP II conformation, such as indolicidin (124)
and
bactenecin (125)
, likely act by crossing cell membranes on
their own. When neutrophils are incubated with the PR-39 peptide, a
proline- and arginine-rich antimicrobial peptide, NADPH oxidase
production of superoxide anion O2- is blocked.
The peptide is presumed to act by binding to the SH3 domains of the
NADPH oxidase subunits, thereby blocking assembly of a functional
enzyme (126)
. Furthermore, when NIH 3T3 cells are
incubated with the 15 residue NH2-terminal
segment of PR-39, the peptide crosses the membrane and binds SH3
domain-containing proteins, such as p130Cas
(127)
.
There has been great interest in designing peptidomimetic antagonists
of protein-protein interactions. Such antagonists should have value in
disrupting specific proteinprotein interactions in the cell for the
purposes of evaluating the functional consequences of the interaction
and drug discovery. Stuart Schreiber and colleagues (Harvard
University) have attempted to design inhibitors of the Src SH3 domain
by initially synthesizing a library of compounds that contained
nonpeptidic elements fused to the NH2 terminus of
the core sequence PLPPLP. A combinatorial library of compounds, which
was synthesized on beads, was incubated with a biotinylated Src SH3
domain, and positive beads were revealed when incubated with
streptavidin-linked alkaline phosphatase and a chromogenic substrate.
Only those beads with nonpeptidic elements that fit into the
specificity pocket of the Src SH3 domain yielded positive beads,
because the Kd of the PLPPLP peptide by itself is 1
mmol/l (128
, 129)
. One ligand was selected for further
development. Through screening a second-generation tuning library,
ligands with nonpeptidic elements were identified that fit the
specificity (130)
and LP pockets (33)
.
Other research groups have attempted to create peptidomimetics of the
scaffolding prolines of SH3 ligands. This could have major consequences
for drug design, because it allows a search for novel functionalities
to replace the proline that can interact with new regions of the SH3
and hence enhance binding. Novel oligomers containing proline analogs
have been observed to adopt a PP II conformation (131
, 132)
. It also appears to be possible to replace proline by other
N-substituted amino acids. Recently, a paper from the laboratory of
Wendell Lim (University of California, San Francisco) demonstrated that
the two prolines in the PxxP motif could tolerate substitution by
N-substituted glycine, or peptoid, residues (133)
.
From a survey of six SH3 domain-peptide ligand pairs, N-substituted
ligands were discovered to bind better than the original peptides. In
particular, one ligand was identified that selectively bound the
NH2-terminal SH3 domain of Grb2 with 100-fold
greater affinity than the original 12-mer peptide sequence. Thus, in
conjunction with cell permeable peptides, it may be possible in the
future to generate peptidomimetics that are potent antagonists of
specific SH3 and WW domain based proteinprotein interactions in
cultured cells and whole animals.
 |
FUTURE PROSPECTS
|
|---|
Availability of complete genomes and proteomes makes it attractive
to analyze a defined number of domains and to predict their cognate
ligands and biochemical/genetic interactions. For example, computer
analysis of the Saccharomyces cerevisiae and
Caenorhabditis elegans genomes has revealed that they
contain potentially 23 and 54 SH3 domain- and 6 and 10 WW
domain-containing proteins, respectively. These domains are currently
being analyzed in terms of their ligand predilections, using
phage-displayed combinatorial peptide libraries, so that the optimal
ligand sequences can be used to identify putative interacting proteins
in either the yeast or nematode proteomes. Once the rules of the
protein recognition code (81)
are more defined and the
structural determinants of the domains are illuminated, one should be
able to make such predictions with the aid of computer
modeling/simulation packages. Such analyses could provide useful
paradigms for analogous future approaches directed toward
characterizing the human proteome.
 |
ACKNOWLEDGMENTS
|
|---|
Supported by grants from the Leukemia Society of America, Muscular
Dystrophy Association, and the NIH. We would like to thank Trevor
Creamer, Michael Eck, Xavier Espanel, Stephan Feller, Sam Gellman,
Jeremy Kasanov, and James Morken for helpful comments on the
manuscript. B. K. K. dedicates this review in memory of his
father.
 |
FOOTNOTES
|
|---|
2 The FASEB Journal cannot guarantee the availability of references to the Web.

 |
REFERENCES
|
|---|
-
Geysen, H. M., Barteling, S. J., Meloen, R. H. (1985) Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein. Proc. Natl. Acad. Sci. USA 82,178-182[Abstract/Free Full Text]
-
Cohen, G. B., Ren, R., Baltimore, D. (1995) Modular binding domains in signal transduction proteins. Cell 80,237-248[Medline]
-
Reuther, G. W., Pendergast, A. M. (1996) The roles of 143-3 proteins in signal transduction. Vitam. Horm. 52,149-175[Medline]
-
Sudol, M. (1996) Structure and function of the WW domain. Prog. Biophys. Mol. Biol. 65,113-132[Medline]
-
Di Fiore, P. P., Pelicci, P. G., Sorkin, A. (1997) EH: a novel protein-protein interaction domain potentially involved in intracellular sorting. Trends Biochem. Sci. 22,411-413[Medline]
-
Pawson, T., Scott, J. D. (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278,2075-2080[Abstract/Free Full Text]
-
Shoelson, S. E. (1997) SH2 and PTB domain interactions in tyrosine kinase signal transduction. Curr. Opin. Chem. Biol. 1,227-234[Medline]
-
Ponting, C. P., Aravind, L., Schultz, J., Bork, P., Koonin, E. V. (1999) Eukaryotic signalling domain homologues in archaea and bacteria. Ancient ancestry and horizontal gene transfer. J. Mol. Biol. 289,729-745[Medline]
-
Koch, C., Anderson, D., Moran, M., Ellis, C., Pawson, T. (1991) SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252,668-674[Abstract/Free Full Text]
-
Bar-Sagi, D., Rotin, D., Batzer, A., Mandiyan, V., Schlessinger, J. (1993) SH3 domains direct cellular localization of signaling molecules. Cell 74,83-91[Medline]
-
Seidel-Dugan, C., Meyer, B. E., Thomas, S. M., Brugge, J. S. (1992) Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src. Mol. Cell. Biol. 12,1835-1845[Abstract/Free Full Text]
-
Franz, W. M., Berger, P., Wang, J. Y. (1989) Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J 8,137-147[Medline]
-
Jackson, P., Baltimore, D. (1989) N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J 8,449-456[Medline]
-
Cicchetti, P., Mayer, B. J., Thiel, G., Baltimore, D. (1992) Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257,803-806[Abstract/Free Full Text]
-
Ren, R., Mayer, B. J., Cicchetti, P., Baltimore, D. (1993) Identification of a ten-amino acid proline-rich SH3 binding site. Science 259,1157-1161[Abstract/Free Full Text]
-
Alexandropoulos, K., Cheng, G., Baltimore, D. (1995) Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Proc. Natl. Acad. Sci. USA 92,3110-3114[Abstract/Free Full Text]
-
Knudsen, B. S., Feller, S. M., Hanafusa, H. (1994) Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk. J. Biol. Chem. 269,32781-32787[Abstract/Free Full Text]
-
Schumacher, C., Knudsen, B. S., Ohuchi, T., Di Fiore, P. P., Glassman, R. H., Hanafusa, H. (1995) The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R. J. Biol. Chem. 270,15341-15347[Abstract/Free Full Text]
-
Feller, R., Ren, R., Hanafusa, H., Baltimore, D. (1994) SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. Trends Biochem. Sci. 19,453-458[Medline]
-
Mayer, B. J., Eck, M. J. (1995) SH3 domains: minding your ps and qs. Curr. Biol. 5,364-367[Medline]
-
Chen, J. K., Lane, W. S., Brauer, A. W., Tanaka, A., Schreiber, S. L. (1993) Biased combinatorial libraries: novel ligands for the SH3 domain of phosphatidylinositol 3-kinase. J. Am. Chem. Soc. 115,12591-12952
-
Cheadle, C., Ivashchenko, Y., South, V., Searfoss, G. H., French, S., Howk, R., Ricca, G. A., Jaye, M. (1994) Identification of a Src SH3 domain binding motif by screening a random phage display library. J. Biol. Chem. 269,24034-24039[Abstract/Free Full Text]
-
Rickles, R. J., Botfield, M. C., Weng, Z., Taylor, J. A., Green, O. M., Brugge, J. S., Zoller, M. J. (1994) Identification of Src, Fyn, Lyn, PI3K, and Abl SH3 domain ligands using phage display libraries. EMBO J 13,5598-5604[Medline]
-
Sparks, A. B., Quilliam, L. A., Thorn, J. M., Der, C. J., Kay, B. K. (1994) Identification and characterization of Src SH3 ligands from phage-displayed random peptide libraries. J. Biol. Chem. 269,23853-23856[Abstract/Free Full Text]
-
Bunnell, S. C., Henry, P. A., Kolluri, R., Kirchhausen, T., Rickles, R. J., Berg, L. J. (1996) Identification of Itk/Tsk Src homology 3 domain ligands. J. Biol. Chem. 271,25646-25656[Abstract/Free Full Text]
-
Quilliam, L. A., Lambert, Q. T., Westwick, J. K., Mickeslon-Young, L. A., Sparks, A. B., Kay, B. K., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Der, C. J. (1996) Isolation of a Nck-associated kinase, PRK2, an SH3-binding protein and potential effector of Rho protein signalling. J. Biol. Chem. 271,28772-28775[Abstract/Free Full Text]
-
Sparks, A., Rider, J., Hoffman, N., Fowlkes, D., Quilliam, L., Kay, B. (1996) Distinct ligand preferences of SH3 domains from Src, Yes, Abl, cortactin, p53BP2, PLC
, Crk, and Grb2. Proc. Natl. Acad. Sci. USA 93,1540-1544[Abstract/Free Full Text]
-
Grabs, D., Slepnev, V. I., Songyang, Z., David, C., Lynch, M., Cantley, L. C., De Camilli, P. (1997) The SH3 domain of amphiphysin binds the proline-rich domain of dynamin at a single site that defines a new SH3 binding consensus sequence. J. Biol. Chem. 272,13419-13425[Abstract/Free Full Text]
-
Feng, S., Chen, J., Yu, H., Simmon, J., Schreiber, S. (1994) Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266,1241-1247[Abstract/Free Full Text]
-
Lim, W. A., Richards, F. M., Fox, R. (1994) Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature (London) 372,375-379[Medline]
-
Saraste, M., Musacchio, A. (1994) Backwards and forwards binding. Nat. Struct. Biol. 1,835-837[Medline]
-
Posern, G., Zheng, J., Knudsen, B. S., Kardinal, C., Muller, K. B., Voss, J., Shishido, T., Cowburn, D., Cheng, G., Wang, B., Kruh, G. D., Burrell, S. K., Jacobson, C. A., Lenz, D. M., Zamborelli, T. J., Adermann, K., Hanafusa, H., Feller, S. M. (1998) Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G. Oncogene 16,1903-1912[Medline]
-
Lee, C.-H., Leung, B., Lemmon, M. A., Zheng, J., Cowburn, D., Kuriyan, J., Sakesla, K. (1995) A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J 14,5006-5015[Medline]
-
Morken, J., Kapoor, T., Feng, S., Shirai, F., Schreiber, S. (1998) Exploring the leucine-proline binding procket to the Src SH3 domain using structure-based, split-pool synthesis and affinity selection. J. Am. Chem. Soc. 120,30-36
-
Feng, S., Kasahara, C., Rickles, R. J., Schreiber, S. L. (1995) Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc. Natl. Acad. Sci. USA 92,12408-12415[Abstract/Free Full Text]
-
Gorina, S., Pavletich, N. P. (1996) Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274,1001-1005[Abstract/Free Full Text]
-
Ruaro, E. M., Collavin, L., Del Sal, G., Haffner, R., Oren, M., Levine, A. J., Schneider, C. (1997) A proline-rich motif in p53 is required for transactivation-independent growth arrest as induced by Gas1. Proc. Natl. Acad. Sci. USA 94,4675-4680[Abstract/Free Full Text]
-
Kishan, K. V., Scita, G., Wong, W. T., Di Fiore, P. P., Newcomer, M. E. (1997) The SH3 domain of Eps8 exists as a novel intertwined dimer. Nat. Struct. Biol. 4,739-743[Medline]
-
Mongiovi, A. M., Romano, P. R., Panni, S., Mendoza, M., Wong, W. T., Musacchio, A., Cesareni, G., Paolo Di Fiore, P. (1999) A novel peptideSH3 interaction. EMBO J 18,5300-5309[Medline]
-
Zhao, H., Okada, S., Pessin, J. E., Koretzky, G. A. (1998) Insulin receptor-mediated dissociation of Grb2 from Sos involves phosphorylation of Sos by kinase(s) other than extracellular signal- regulated kinase. J. Biol. Chem. 273,12061-12067[Abstract/Free Full Text]
-
Wu, Y., Spencer, S. D., Lasky, L. A. (1998) Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein. J. Biol. Chem. 273,5765-5770[Abstract/Free Full Text]
-
Comer, A. R., Ahern-Djamali, S. M., Juang, J. L., Jackson, P. D., Hoffmann, F. M. (1998) Phosphorylation of Enabled by the Drosophila Abelson tyrosine kinase regulates the in vivo function and protein-protein interactions of Enabled. Mol. Cell. Biol. 18,152-160[Abstract/Free Full Text]
-
Appella, D., Christianson, L., Karle, I., Powell, D., Gellman, S. (1996) ß-peptide foldamers: robust helix formation in a new family of ß-amino acid oligomers. J. Am. Chem. Soc. 118,13071-13072
-
Nguyen, J. T., Lim, W. A. (1997) How Src exercises self-restraint. Nat. Struct. Biol. 4,256-260[Medline]
-
Parrini, M. C., Mayer, B. J. (1999) Engineering temperature-sensitive SH3 domains. Chem. Biol. 6,679-687[Medline]
-
Williams, J. C., Weijland, A., Gonfloni, S., Thompson, A., Courtneidge, S. A., Superti-Furga, G., Wierenga, R. K. (1997) The 2.35 Å crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions. J. Mol. Biol. 274,757-775[Medline]
-
Xu, W., Harrison, S. C., Eck, M. J. (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature (London) 385,595-602[Medline]
-
Moarefi, I., LaFevre-Bernt, M., Sicheri, F., Huse, M., Lee, C. H., Kuriyan, J., Miller, W. T. (1997) Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature (London) 385,650-653[Medline]
-
Sicheri, F., Moarefi, I., Kuriyan, J. (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature (London) 385,602-609[Medline]
-
Barila, D., Superti-Furga, G. (1998) An intramolecular SH3-domain interaction regulates c-Abl activity. Nat. Genet. 18,280-282[Medline]
-
Williams, J. C., Wierenga, R. K., Saraste, M. (1998) Insights into Src kinase functions: structural comparisons. Trends Biochem. Sci. 23,179-184[Medline]
-
Jackson, P. K., Paskind, M., Baltimore, D. (1993) Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl. Oncogene 8,1943-1956[Medline]
-
Andreotti, A. H., Bunnell, S. C., Feng, S., Berg, L. J., Schreiber, S. L. (1997) Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature (London) 385,93-97[Medline]
-
Bork, P., Sudol, M. (1994) The WW domain: a signalling site in dystrophin?. Trends Biochem. Sci 19,531-533[Medline]
-
Chen, H. I., Sudol, M. (1995) The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc. Natl. Acad. Sci. USA 92,7819-7823[Abstract/Free Full Text]
-
Macias, M. J., Hyvonen, M., Baraldi, E., Schultz, J., Sudol, M., Saraste, M., Oschkinat, H. (1996) Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature (London) 382,646-649[Medline]
-
Sudol, M. (1996) The WW module competes with the SH3 domain?. Trends Biochem. Sci. 21,161-163[Medline]
-
Bedford, M. T., Chan, D. C., Leder, P. (1997) FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. EMBO J 16,2376-2383[Medline]
-
Linn, H., Ermekova, K. S., Rentschler, S., Sparks, A. B., Kay, B. K., Sudol, M. (1997) Using molecular repertoires to identify high-affinity peptide ligands of the WW domain of human and mouse YAP. Biol. Chem. 378,531-537[Medline]
-
Bedford, M. T., Reed, R., Leder, P. (1998) WW domain-mediated interactions reveal a spliceosome-associated protein that binds a third class of proline-rich motif: the proline glycine and methionine-rich motif. Proc. Natl. Acad. Sci. USA 95,10602-10607[Abstract/Free Full Text]
-
Ranganathan, R., Lu, K. P., Hunter, T., Noel, J. P. (1997) Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 89,875-886[Medline]
-
Ibragimova, G. T., Wade, R. C. (1998) Importance of explicit salt ions for protein stability in molecular dynamics simulation. Biophys. J. 74,2906-2911[Abstract/Free Full Text]
-
Mosser, E. A., Kasanov, J. D., Forsberg, E. C., Kay, B. K., Ney, P. A., Bresnick, E. H. (1998) Physical and functional interactions between the transactivation domain of the hematopoietic transcription factor NF-E2 and WW domains. Biochemistry 37,13686-13695[Medline]
-
Lu, P. J., Zhou, X. Z., Shen, M., Lu, K. P. (1999) Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283,1325-1328[Abstract/Free Full Text]
-
Chen, H. I., Einbond, A., Kwak, S. J., Linn, H., Koepf, E., Peterson, S., Kelly, J. W., Sudol, M. (1997) Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands. J. Biol. Chem. 272,17070-17077[Abstract/Free Full Text]
-
Einbond, A., Sudol, M. (1996) Towards prediction of cognate complexes between the WW domain and proline-rich ligands. FEBS Letters 384,1-8[Medline]
-
Ermekova, K. S., Zambrano, N., Linn, H., Minopoli, G., Gertler, F., Russo, T., Sudol, M. (1997) The WW domain of neural protein FE65 interacts with proline-rich motifs in mena, the mammalian homolog of Drosophila enabled. J. Biol. Chem. 272,32869-32877[Abstract/Free Full Text]
-
Schild, L., Lu, Y., Gautschi, I., Schneeberger, E., Lifton, R. P., Rossier, B. C. (1996) Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome. EMBO J 15,2381-2387[Medline]
-
Staub, O., Dho, S., Henry, P., Correa, J., Ishikawa, T., McGlade, J., Rotin, D. (1996) WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddles syndrome. EMBO J 15,2371-2380[Medline]
-
Faber, P. W., Barnes, G. T., Srinidhi, J., Chen, J., Gusella, J. F., MacDonald, M. E. (1998) Huntingtin interacts with a family of WW domain proteins. Hum. Mol. Genet. 7,1463-1474[Abstract/Free Full Text]
-
Rentschler, S., Linn, H., Deininger, K., Bedford, M. T., Espanel, X., Sudol, M. (1999) The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan. Biol. Chem. 380,431-442[Medline]
-
Hansson, J. H., Schild, L., Lu, Y., Wilson, T. A., Gautschi, I., Shimkets, R., Nelson-Williams, C., Rossier, B. C., Lifton, R. P. (1995) A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc. Natl. Acad. Sci. USA 92,11495-11499[Abstract/Free Full Text]
-
Tamura, H., Schild, L., Enomoto, N., Matsui, N., Marumo, F., Rossier, B. C. (1996) Liddle disease caused by a missense mutation of beta subunit of the epithelial sodium channel gene. J. Clin. Invest. 97,1780-1784[Medline]
-
Inoue, J., Iwaoka, T., Tokunaga, H., Takamune, K., Naomi, S., Araki, M., Takahama, K., Yamaguchi, K., Tomita, K. (1998) A family with Liddles syndrome caused by a new missense mutation in the beta subunit of the epithelial sodium channel. J. Clin. Endocrinol. Metab. 83,2210-2213[Abstract/Free Full Text]
-
Kumar, S., Tomooka, Y., Noda, M. (1992) Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem. Biophys. Res. Comm. 185,1155-1161[Medline]
-
Staub, O., Gautschi, I., Ishikawa, T., Breitschopf, K., Ciechanover, A., Schild, L., Rotin, D. (1997) Regulation of stability and function of the epithelial Na+ channel (ENaC) by ubiquitination. EMBO J 16,6325-6336[Medline]
-
Matsumoto, P. S., Ohara, A., Duchatelle, P., Eaton, D. C. (1993) Tyrosine kinase regulates epithelial sodium transport in A6 cells. Am. J. Physiol. 264,C246-C250[Abstract/Free Full Text]
-
Shimkets, R. A., Lifton, R., Canessa, C. M. (1998) In vivo phosphorylation of the epithelial sodium channel. Proc. Natl. Acad. Sci. USA 95,3301-3305[Abstract/Free Full Text]
-
Gavva, N. R., Gavva, R., Ermekova, K., Sudol, M., Shen, C. J. (1997) Interaction of WW domains with hematopoietic transcription factor p45/NF-E2 and RNA polymerase II. J. Biol. Chem. 272,24105-24108[Abstract/Free Full Text]
-
Yagi, R., Chen, L. F., Shigesada, K., Murakami, Y., Ito, Y. (1999) A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J 18,2551-2562[Medline]
-
Komuro, A., Saeki, M., Kato, S. (1999) Npw38, a novel nuclear protein possessing a WW domain capable of activating basal transcription. Nucleic Acids Res 27,1957-1965[Abstract/Free Full Text]
-
Waragai, M., Lammers, C. H., Takeuchi, S., Imafuku, I., Udagawa, Y., Kanazawa, I., Kawabata, M., Mouradian, M. M., Okazawa, H. (1999) PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum. Mol. Genet. 8,977-987[Abstract/Free Full Text]
-
Sudol, M. (1998) From Src Homology domains to other signaling modules: proposal of the protein recognition code. Oncogene 17,1469-1474[Medline]
-
Reinhard, M., Rudiger, M., Jockusch, B. M., Walter, U. (1996) VASP interaction with vinculin: a recurring theme of interactions with proline-rich motifs. FEBS Lett 399,103-107[Medline]
-
Gertler, F. B., Niebuhr, K., Reinhard, M., Wehland, J., Soriano, P. (1996) Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 87,227-239[Medline]
-
Niebuhr, K., Ebel, F., Frank, R., Reinhard, M., Domann, E., Carl, U. D., Walter, U., Gertler, F. B., Wehland, J., Chakraborty, T. (1997) A novel proline-rich motif present in ActA of listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family. EMBO J 16,5433-5444[Medline]
-
Symons, M., Derry, J., Karlak, B., Jiang, S., Lemahieu, V., McCormick, F., Francke, U., Abo, A. (1996) Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84,723-734[Medline]